Liu Y, Tian S, Thaker H, Dong M
Toxins (Basel). 2021; 13(3).
PMID: 33803852
PMC: 8003205.
DOI: 10.3390/toxins13030222.
Menge C
Toxins (Basel). 2020; 12(5).
PMID: 32456125
PMC: 7290813.
DOI: 10.3390/toxins12050345.
Brandelli J, Griener T, Laing A, Mulvey G, Armstrong G
Toxins (Basel). 2015; 7(10):4054-66.
PMID: 26473922
PMC: 4626720.
DOI: 10.3390/toxins7104054.
Russo L, Melton-Celsa A, Smith M, OBrien A
PLoS One. 2014; 9(3):e93463.
PMID: 24671194
PMC: 3966898.
DOI: 10.1371/journal.pone.0093463.
Takeda Y
Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87(1):1-12.
PMID: 21233598
PMC: 3035056.
DOI: 10.2183/pjab.87.1.
Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.
Sheoran A, Chapman-Bonofiglio S, Harvey B, Mukherjee J, Georgiou G, Donohue-Rolfe A
Infect Immun. 2005; 73(8):4607-13.
PMID: 16040972
PMC: 1201267.
DOI: 10.1128/IAI.73.8.4607-4613.2005.
Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1.
Harrison L, van Haaften W, Tesh V
Infect Immun. 2004; 72(5):2618-27.
PMID: 15102770
PMC: 387879.
DOI: 10.1128/IAI.72.5.2618-2627.2004.
Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.
Taylor Jr F, Tesh V, DeBault L, Li A, Chang A, Kosanke S
Am J Pathol. 1999; 154(4):1285-99.
PMID: 10233866
PMC: 1866558.
DOI: 10.1016/S0002-9440(10)65380-1.
Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.
Paton J, Paton A
Clin Microbiol Rev. 1998; 11(3):450-79.
PMID: 9665978
PMC: 88891.
DOI: 10.1128/CMR.11.3.450.
Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine.
Bosworth B, Samuel J, Moon H, OBrien A, Gordon V, Whipp S
Infect Immun. 1996; 64(1):55-60.
PMID: 8557374
PMC: 173727.
DOI: 10.1128/iai.64.1.55-60.1996.
Minimum domain of the Shiga toxin A subunit required for enzymatic activity.
Haddad J, Al-Jaufy A, Jackson M
J Bacteriol. 1993; 175(16):4970-8.
PMID: 8349540
PMC: 204961.
DOI: 10.1128/jb.175.16.4970-4978.1993.
Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice.
Tesh V, Burris J, Owens J, Gordon V, Wadolkowski E, OBrien A
Infect Immun. 1993; 61(8):3392-402.
PMID: 8335369
PMC: 281015.
DOI: 10.1128/iai.61.8.3392-3402.1993.
Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice.
Barrett T, Potter M, Wachsmuth I
Infect Immun. 1989; 57(11):3434-7.
PMID: 2680974
PMC: 259847.
DOI: 10.1128/iai.57.11.3434-3437.1989.
Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.
Macleod D, Gyles C, Valdivieso-Garcia A, Clarke R
Infect Immun. 1991; 59(4):1300-6.
PMID: 2004812
PMC: 257842.
DOI: 10.1128/iai.59.4.1300-1306.1991.
Detection and production of verotoxin 1 of Escherichia coli O157:H7 in food.
Weeratna R, Doyle M
Appl Environ Microbiol. 1991; 57(10):2951-5.
PMID: 1746955
PMC: 183903.
DOI: 10.1128/aem.57.10.2951-2955.1991.